Table 2.
Secondary performance measures for the Improving Care for Cardiovascular Disease in China-atrial fibrillation project
| Reference | Title of performance measure | Proportion, % (numerator/denominator) |
| 22 | Proportion of non-valvular AF patients who had a CHADS2 score reported | 15.0 (3422/22 864) |
| 7, 22 | Proportion of non-valvular AF patients who had a CHA2DS2-VASc score reported | 19.2 (4397/22 864) |
| 7, 22 | Proportion of AF patients who have a documented resting heart rate of <80 bpm closest to discharge | 65.0 (7140/10 989) |
| 7, 22 | Proportion of AF patients receiving anticoagulation therapy education | 89.4 (10 941/12 243) |
| 7, 22 | Proportion of AF patients receiving conventional medical education | 89.3 (25 547/28 615) |
| 20 | Proportion of AF patients with indication prescribed aldosterone antagonist at discharge* | 72.2 (888/1230) |
| 7, 22 | Proportion valvular AF patients prescribed warfarin at discharge | 52.4 (2010/3838) |
| 20 | Proportion of AF patients who are given smoking cessation advice or counselling | 22.5 (1263/5623) |
| Composite scores of secondary performance measures | 51.4 (55 608/108 266) |
*Indications refer to acute myocardial infarction patients with left ventricular ejection fraction <40% or heart failure or diabetes mellitus; or the heart failure patients with left ventricular ejection fraction <35%.